Amneal Completes Kashiv Takeover

Bolsters Capabilities In Complex Generics And 505(b)(2) Hybrid Drugs

 
• By David Wallace
  
2.0 Wireframe
The deal is the latest step towards “Amneal 2.0” • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business